Image

Evaluation of Chronic Liver Disease Condition and Transplant Prognosis Assisted by Eye Biological Parameters

Evaluation of Chronic Liver Disease Condition and Transplant Prognosis Assisted by Eye Biological Parameters

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study investigates the correlation between ocular biological characteristics and overall conditions before and after liver transplantation by collecting ocular biological characteristics. Explore whether it is possible to construct a clinical prediction model for liver transplantation by incorporating ocular biometric features, in order to optimize disease management before and after liver transplantation.

Description

This study is a bidirectional cohort study, which retrospectively analysed data from a prospective database to construct a model, and prospectively collected patient information from preoperative to postoperative for model improvement and validation.

Eligibility

Inclusion Criteria:

  1. Age greater than or equal to 18 years old;
  2. Late stage liver disease patients waiting for liver transplantation treatment, as well as patients with varying degrees of cirrhosis;
  3. Can collect complete basic demographic information, liver function blood test indicators, liver pathology and imaging examination results;
  4. Can cooperate with eye OCT, OCTA and other examinations, and obtain qualified examination parameters;
  5. Voluntarily follow the clinical trial protocol and sign the informed consent form.

Exclusion Criteria:

  1. History of other organ transplant surgeries;
  2. History of intraocular laser treatment, medication injection, and surgery;
  3. History of high myopia, glaucoma, and retinal choroidal related eye diseases;
  4. History of major systemic diseases other than liver disease;
  5. Individuals whose overall body and eye conditions cannot cooperate with eye examinations.

Study details
    Diagnostic Techniques
    Ophthalmological
    Liver Transplantation
    Liver Cirrhoses

NCT06756009

Zhongshan Ophthalmic Center, Sun Yat-sen University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.